These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 4843281)

  • 21. Clinical comparison of locetamic acid, lopanoic acid and tyropanoate sodium.
    Marshall TR
    J Indiana State Med Assoc; 1976 Oct; 69(10):742-3. PubMed ID: 135811
    [No Abstract]   [Full Text] [Related]  

  • 22. Conjugated sodium tyropanoate (Bilopaque) in the bowel: significance of its presence or absence after first-dose oral cholecystography.
    Muhletaler CA; Gerlock AJ; Avant GR
    Radiology; 1981 Nov; 141(2):311-6. PubMed ID: 7291552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Trial of Bilopaque, a new contrast medium for oral cholecystography].
    Magos E; Delhaye J; Dejong M
    J Belge Radiol; 1976; 59(4):369-76. PubMed ID: 795805
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinico-radiological study of 3 radiopaque substances used in oral cholecystography].
    Ipinza I
    Rev Med Chil; 1982 Aug; 110(8):761-5. PubMed ID: 7156610
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of the opacifying characteristics and pharmacologic responses of iocetamic acid (Cholebrine), a new oral cholecystographic agent, with sodium tyropanoate (Bilopaque).
    Wishart DL; Dotter CT
    Am J Roentgenol Radium Ther Nucl Med; 1973 Oct; 119(2):429-32. PubMed ID: 4748234
    [No Abstract]   [Full Text] [Related]  

  • 26. [Double-blind study of a new gallbladder contrast medium].
    Fork FT
    Lakartidningen; 1977 Mar; 74(10):915-7. PubMed ID: 138777
    [No Abstract]   [Full Text] [Related]  

  • 27. A comparative evaluation of a new oral cholecystographic agent bilopaque with orabilex.
    JUDKINS MP BILLIMORIA PE; DOTTER CT
    Am J Roentgenol Radium Ther Nucl Med; 1963 Apr; 89():859-63. PubMed ID: 14042043
    [No Abstract]   [Full Text] [Related]  

  • 28. Time of optimal gallbladder opacification with telepaque (lopanoic acid).
    Whalen JP; Rizzuti RJ; Evans JA
    Radiology; 1972 Dec; 105(3):523-4. PubMed ID: 4635088
    [No Abstract]   [Full Text] [Related]  

  • 29. Concentration and excretion of contrast agents during oral cholecystography as measured by computed tomography in dogs.
    Hunter TB; Fon GT; Berk RN; Capp MP
    Gastrointest Radiol; 1981; 6(4):349-52. PubMed ID: 7308718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The effect of diarrhea on gallbladder opacification during oral cholecystography: comparison of two cholecystographic agents (author's transl)].
    Fukuda K; Nanjo M; Harada J; Sekiya T; Kanehira Y; Anno I; Takayama M; Watanabe H; Yamada T; Yamaguchi M; Tada S
    Rinsho Hoshasen; 1979 Mar; 24(3):379-84. PubMed ID: 547079
    [No Abstract]   [Full Text] [Related]  

  • 31. Tyropanoate cholecystography early in the course of acute pancreatitis.
    Longstreth GF; Slivka J
    J Clin Gastroenterol; 1981; 3 Suppl 1():47-50. PubMed ID: 7328298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical and chemical aspects of residual contrast media in the intestine during oral cholecystography with Trijobil and Falignost].
    Quasdorf M; Becker C; Quasdorf G; Becker HW
    Radiol Diagn (Berl); 1977; 18(1):19-28. PubMed ID: 866607
    [No Abstract]   [Full Text] [Related]  

  • 33. Determinants of the rate of intestinal absorption of oral cholecystographic contrast agents in the dog jejunum.
    Janes JO; Dietschy JM; Berk RN; Loeb PM; Barnhart JL
    Gastroenterology; 1979 May; 76(5 Pt 1):970-7. PubMed ID: 155546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Oral gallbladder contrast agents in liver damage].
    Ordnung W; Müting D
    Med Klin; 1980 Aug; 75(17):618-20. PubMed ID: 7412711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of three oral cholecystographic agents on laboratory data. Clinical chemical determinations and urinary tests (author's transl)].
    Kasezawa N; Tazawa R; Urushibata S; Kobayashi M
    Rinsho Byori; 1974 Jun; 22(6):440-4. PubMed ID: 4472714
    [No Abstract]   [Full Text] [Related]  

  • 36. Single dose oral cholecystography.
    Krook PM; Bush WH
    Radiology; 1978 Jun; 127(3):643-4. PubMed ID: 663149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subjective vs. objective evaluation of gallbladder opacification during oral cholecystography in comparative clinical trials: implications for studies involving visual assessment.
    Fon GT; Hunter TB; Berk RN; Patton DD; Capp MP
    Radiology; 1982 Jul; 144(2):277-80. PubMed ID: 7089280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacology of oral cholecystography].
    Gaón D
    Acta Gastroenterol Latinoam; 1980; 10(3):231-41. PubMed ID: 7013405
    [No Abstract]   [Full Text] [Related]  

  • 39. RENAL TOXICITY OF ORAL CHOLECYSTOGRAPHIC MEDIA. BUNAMIODYL SODIUM AND IOPANOIC ACID.
    WENNBERG JE; OKUN R; HINMAN EJ; NORTHCUTT RC; GRIEP RJ; WALKER WG
    JAMA; 1963 Nov; 186():461-7. PubMed ID: 14085024
    [No Abstract]   [Full Text] [Related]  

  • 40. The influence of fasting on opacification of the gallbladder during oral cholecystography using two consecutive doses in a canine model.
    Thoeni RF; Moss AA; Stoughton JA
    Invest Radiol; 1979; 14(3):228-32. PubMed ID: 468495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.